It is a pharma private limited company based in Kozhikode, Kerala, India, established in 2015.
2015 | Kozhikode, Kerala, India | ActiveMax Briston Pharmaceutical Private Limited, a active private limited company, was established on 18 August 2015 in Kozhikode, Kerala, India. Engaging in pharmaceutical retailers & distributors within the pharma sector, it holds CIN: U24297KL2015PTC039023. Registered under ROC Roc Ernakulam. it is unlisted. It has an authorized capital of ₹0.50 M and a paid-up capital of ₹0.50 M.
It upholds a compliant status. Its leadership includes Sudheer Gangadharan (Director), Sindhu Chittakkudy (Director). Past directors included Pulloor Harish, Sugdev Nalukudi Parambil Krishna, Sarath Chandran Sreedharan Nambikeriyil. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Bharath Towers, Near Arya Samajam, Rammohan Road, P.O. Puthiyara, Kozhikode, Kerala, 673004.
U24297KL2015PTC039023
039023
18 August 2015
₹0.50 M
₹0.50 M
Roc Ernakulam
Unlisted
Active
Explore comprehensive insights into Max Briston Pharmaceutical Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sudheer Gangadharan | Director | 18 Aug 2015 | Current |
| Sindhu Chittakkudy | Director | 05 Apr 2021 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Managing Director | 24 Sep 2018 | Past |
| Pramod Abcsdd | Director | 24 Sep 2018 | Past |
| Pramod Abcsdd | Director | 05 Apr 2021 | Past |
| Pramod Abcsdd | Director | 24 Sep 2018 | Past |
| Pramod Abcsdd | Director | 05 Apr 2021 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Max Briston Pharmaceutical Private Limited, for the financial year ended 2019, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
Unlock access to Max Briston Pharmaceutical's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Max Briston Pharmaceutical, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Max Briston Pharmaceutical, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Max Briston Pharmaceutical's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Max Briston Pharmaceutical Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
Progress on Max Briston Pharmaceutical Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Ernakulam. was documented.
The activity Sindhu Chittakkudy was appointed as a Director was appointed as a Director on 05 Apr 2021 & has been associated with this company since 4 years 8 months . was completed.
Sudheer Gangadharan was appointed as a Director was appointed as a Director on 18 Aug 2015 & has been associated with this company since 10 years 4 months . was recorded as a recent event.
Max Briston Pharmaceutical Private Limited was registered on 18 Aug 2015 with Roc Ernakulam & aged 10 years 4 months as per MCA records. was recorded as a recent event.
The CIN of Max Briston Pharmaceutical Private Limited is U24297KL2015PTC039023.
Max Briston Pharmaceutical Private Limited is headquartered at Bharath Towers, Near Arya Samajam, Rammohan Road, P.O. Puthiyara, Kozhikode, Kerala, 673004.
Max Briston Pharmaceutical Private Limited was incorporated on 18 August 2015.
The current directors of Max Briston Pharmaceutical Private Limited are
The primary industry of Max Briston Pharmaceutical Private Limited is Pharma.
Max Briston Pharmaceutical Private Limited is unlisted.
The authorized capital of Max Briston Pharmaceutical Private Limited is ₹0.50 M, and the paid-up capital is ₹0.50 M.
The compliance status of Max Briston Pharmaceutical Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX